Global Pet Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026


Mar, 2021 | Report ID: 171297 | 156 | Pharmaceuticals and Healthcare

The Pet Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pet Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pet Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Pet Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Antiparasitic Drugs

Antibacterial

Other

Market segment by Application, can be divided into

Dogs

Cats

Other

Market segment by players, this report covers

Zoetis

Boehringer Ingelheim

Merck Animal Health

Elanco Animal Health

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Meiji

Ouro Fino Saude

Parnell

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pet Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pet Drug, with revenue, gross margin and global market share of Pet Drug from 2019 to 2021.

Chapter 3, the Pet Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Pet Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Pet Drug research findings and conclusion, appendix and data source.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pet Drug

1.2 Classification of Pet Drug by Type

1.2.1 Overview: Global Pet Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Pet Drug Revenue Market Share by Type in 2020

1.2.3 Antiparasitic Drugs

1.2.4 Antibacterial

1.2.5 Other

1.3 Global Pet Drug Market by Application

1.3.1 Overview: Global Pet Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Dogs

1.3.3 Cats

1.3.4 Other

1.4 Global Pet Drug Market Size & Forecast

1.5 Global Pet Drug Market Size and Forecast by Region

1.5.1 Global Pet Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Pet Drug Market Size by Region, (2016-2021)

1.5.3 North America Pet Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Pet Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Pet Drug Market Size and Prospect (2016-2026)

1.5.6 South America Pet Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Pet Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pet Drug Market Drivers

1.6.2 Pet Drug Market Restraints

1.6.3 Pet Drug Trends Analysis

2 Company Profiles

2.1 Zoetis

2.1.1 Zoetis Details

2.1.2 Zoetis Major Business

2.1.3 Zoetis Pet Drug Product and Solutions

2.1.4 Zoetis Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Zoetis Recent Developments and Future Plans

2.2 Boehringer Ingelheim

2.2.1 Boehringer Ingelheim Details

2.2.2 Boehringer Ingelheim Major Business

2.2.3 Boehringer Ingelheim Pet Drug Product and Solutions

2.2.4 Boehringer Ingelheim Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Boehringer Ingelheim Recent Developments and Future Plans

2.3 Merck Animal Health

2.3.1 Merck Animal Health Details

2.3.2 Merck Animal Health Major Business

2.3.3 Merck Animal Health Pet Drug Product and Solutions

2.3.4 Merck Animal Health Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Merck Animal Health Recent Developments and Future Plans

2.4 Elanco Animal Health

2.4.1 Elanco Animal Health Details

2.4.2 Elanco Animal Health Major Business

2.4.3 Elanco Animal Health Pet Drug Product and Solutions

2.4.4 Elanco Animal Health Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Elanco Animal Health Recent Developments and Future Plans

2.5 Virbac

2.5.1 Virbac Details

2.5.2 Virbac Major Business

2.5.3 Virbac Pet Drug Product and Solutions

2.5.4 Virbac Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Virbac Recent Developments and Future Plans

2.6 Dechra Veterinary Products

2.6.1 Dechra Veterinary Products Details

2.6.2 Dechra Veterinary Products Major Business

2.6.3 Dechra Veterinary Products Pet Drug Product and Solutions

2.6.4 Dechra Veterinary Products Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Dechra Veterinary Products Recent Developments and Future Plans

2.7 Ceva

2.7.1 Ceva Details

2.7.2 Ceva Major Business

2.7.3 Ceva Pet Drug Product and Solutions

2.7.4 Ceva Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Ceva Recent Developments and Future Plans

2.8 Vetoquinol

2.8.1 Vetoquinol Details

2.8.2 Vetoquinol Major Business

2.8.3 Vetoquinol Pet Drug Product and Solutions

2.8.4 Vetoquinol Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Vetoquinol Recent Developments and Future Plans

2.9 Meiji

2.9.1 Meiji Details

2.9.2 Meiji Major Business

2.9.3 Meiji Pet Drug Product and Solutions

2.9.4 Meiji Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Meiji Recent Developments and Future Plans

2.10 Ouro Fino Saude

2.10.1 Ouro Fino Saude Details

2.10.2 Ouro Fino Saude Major Business

2.10.3 Ouro Fino Saude Pet Drug Product and Solutions

2.10.4 Ouro Fino Saude Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Ouro Fino Saude Recent Developments and Future Plans

2.11 Parnell

2.11.1 Parnell Details

2.11.2 Parnell Major Business

2.11.3 Parnell Pet Drug Product and Solutions

2.11.4 Parnell Pet Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Parnell Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pet Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Pet Drug Players Market Share

3.2.2 Top 10 Pet Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Pet Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pet Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Pet Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Pet Drug Revenue Market Share by Application (2016-2021)

5.2 Pet Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Pet Drug Revenue by Type (2016-2026)

6.2 North America Pet Drug Revenue by Application (2016-2026)

6.3 North America Pet Drug Market Size by Country

6.3.1 North America Pet Drug Revenue by Country (2016-2026)

6.3.2 United States Pet Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Pet Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Pet Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Pet Drug Revenue by Type (2016-2026)

7.2 Europe Pet Drug Revenue by Application (2016-2026)

7.3 Europe Pet Drug Market Size by Country

7.3.1 Europe Pet Drug Revenue by Country (2016-2026)

7.3.2 Germany Pet Drug Market Size and Forecast (2016-2026)

7.3.3 France Pet Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Pet Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Pet Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Pet Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pet Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Pet Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Pet Drug Market Size by Region

8.3.1 Asia-Pacific Pet Drug Revenue by Region (2016-2026)

8.3.2 China Pet Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Pet Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Pet Drug Market Size and Forecast (2016-2026)

8.3.5 India Pet Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Pet Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Pet Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Pet Drug Revenue by Type (2016-2026)

9.2 South America Pet Drug Revenue by Application (2016-2026)

9.3 South America Pet Drug Market Size by Country

9.3.1 South America Pet Drug Revenue by Country (2016-2026)

9.3.2 Brazil Pet Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Pet Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pet Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Pet Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Pet Drug Market Size by Country

10.3.1 Middle East & Africa Pet Drug Revenue by Country (2016-2026)

10.3.2 Turkey Pet Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Pet Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Pet Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pet Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Pet Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Pet Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Pet Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Pet Drug Revenue Market Share by Region (2021-2026)

Table 6. Zoetis Corporate Information, Head Office, and Major Competitors

Table 7. Zoetis Major Business

Table 8. Zoetis Pet Drug Product and Solutions

Table 9. Zoetis Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 11. Boehringer Ingelheim Major Business

Table 12. Boehringer Ingelheim Pet Drug Product and Solutions

Table 13. Boehringer Ingelheim Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Merck Animal Health Corporate Information, Head Office, and Major Competitors

Table 15. Merck Animal Health Major Business

Table 16. Merck Animal Health Pet Drug Product and Solutions

Table 17. Merck Animal Health Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Elanco Animal Health Corporate Information, Head Office, and Major Competitors

Table 19. Elanco Animal Health Major Business

Table 20. Elanco Animal Health Pet Drug Product and Solutions

Table 21. Elanco Animal Health Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Virbac Corporate Information, Head Office, and Major Competitors

Table 23. Virbac Major Business

Table 24. Virbac Pet Drug Product and Solutions

Table 25. Virbac Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Dechra Veterinary Products Corporate Information, Head Office, and Major Competitors

Table 27. Dechra Veterinary Products Major Business

Table 28. Dechra Veterinary Products Pet Drug Product and Solutions

Table 29. Dechra Veterinary Products Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Ceva Corporate Information, Head Office, and Major Competitors

Table 31. Ceva Major Business

Table 32. Ceva Pet Drug Product and Solutions

Table 33. Ceva Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Vetoquinol Corporate Information, Head Office, and Major Competitors

Table 35. Vetoquinol Major Business

Table 36. Vetoquinol Pet Drug Product and Solutions

Table 37. Vetoquinol Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Meiji Corporate Information, Head Office, and Major Competitors

Table 39. Meiji Major Business

Table 40. Meiji Pet Drug Product and Solutions

Table 41. Meiji Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Ouro Fino Saude Corporate Information, Head Office, and Major Competitors

Table 43. Ouro Fino Saude Major Business

Table 44. Ouro Fino Saude Pet Drug Product and Solutions

Table 45. Ouro Fino Saude Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Parnell Corporate Information, Head Office, and Major Competitors

Table 47. Parnell Major Business

Table 48. Parnell Pet Drug Product and Solutions

Table 49. Parnell Pet Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Pet Drug Revenue (USD Million) by Players (2019-2021)

Table 51. Global Pet Drug Revenue Share by Players (2019-2021)

Table 52. Breakdown of Pet Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Pet Drug Players Head Office, Products and Services Provided

Table 54. Pet Drug Mergers & Acquisitions in the Past Five Years

Table 55. Pet Drug New Entrants and Expansion Plans

Table 56. Global Pet Drug Revenue (USD Million) by Type (2016-2021)

Table 57. Global Pet Drug Revenue Share by Type (2016-2021)

Table 58. Global Pet Drug Revenue Forecast by Type (2021-2026)

Table 59. Global Pet Drug Revenue by Application (2016-2021)

Table 60. Global Pet Drug Revenue Forecast by Application (2021-2026)

Table 61. North America Pet Drug Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Pet Drug Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Pet Drug Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Pet Drug Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Pet Drug Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Pet Drug Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Pet Drug Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Pet Drug Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Pet Drug Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Pet Drug Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Pet Drug Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Pet Drug Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Pet Drug Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Pet Drug Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Pet Drug Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Pet Drug Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Pet Drug Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Pet Drug Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Pet Drug Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Pet Drug Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Pet Drug Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Pet Drug Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Pet Drug Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Pet Drug Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Pet Drug Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Pet Drug Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Pet Drug Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Pet Drug Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Pet Drug Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Pet Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Pet Drug Picture

Figure 2. Global Pet Drug Revenue Market Share by Type in 2020

Figure 3. Antiparasitic Drugs

Figure 4. Antibacterial

Figure 5. Other

Figure 6. Pet Drug Revenue Market Share by Application in 2020

Figure 7. Dogs Picture

Figure 8. Cats Picture

Figure 9. Other Picture

Figure 10. Global Pet Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Pet Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Pet Drug Revenue Market Share by Region (2016-2026)

Figure 13. Global Pet Drug Revenue Market Share by Region in 2020

Figure 14. North America Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Pet Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Pet Drug Market Drivers

Figure 20. Pet Drug Market Restraints

Figure 21. Pet Drug Market Trends

Figure 22. Zoetis Recent Developments and Future Plans

Figure 23. Boehringer Ingelheim Recent Developments and Future Plans

Figure 24. Merck Animal Health Recent Developments and Future Plans

Figure 25. Elanco Animal Health Recent Developments and Future Plans

Figure 26. Virbac Recent Developments and Future Plans

Figure 27. Dechra Veterinary Products Recent Developments and Future Plans

Figure 28. Ceva Recent Developments and Future Plans

Figure 29. Vetoquinol Recent Developments and Future Plans

Figure 30. Meiji Recent Developments and Future Plans

Figure 31. Ouro Fino Saude Recent Developments and Future Plans

Figure 32. Parnell Recent Developments and Future Plans

Figure 33. Global Pet Drug Revenue Share by Players in 2020

Figure 34. Pet Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 35. Global Top 3 Players Pet Drug Revenue Market Share in 2020

Figure 36. Global Top 10 Players Pet Drug Revenue Market Share in 2020

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 38. Global Pet Drug Revenue Share by Type in 2020

Figure 39. Global Pet Drug Market Share Forecast by Type (2021-2026)

Figure 40. Global Pet Drug Revenue Share by Application in 2020

Figure 41. Global Pet Drug Market Share Forecast by Application (2021-2026)

Figure 42. North America Pet Drug Sales Market Share by Type (2016-2026)

Figure 43. North America Pet Drug Sales Market Share by Application (2016-2026)

Figure 44. North America Pet Drug Revenue Market Share by Country (2016-2026)

Figure 45. United States Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Canada Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Mexico Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Europe Pet Drug Sales Market Share by Type (2016-2026)

Figure 49. Europe Pet Drug Sales Market Share by Application (2016-2026)

Figure 50. Europe Pet Drug Revenue Market Share by Country (2016-2026)

Figure 51. Germany Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. France Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. United Kingdom Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Russia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Italy Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Asia-Pacific Pet Drug Sales Market Share by Type (2016-2026)

Figure 57. Asia-Pacific Pet Drug Sales Market Share by Application (2016-2026)

Figure 58. Asia-Pacific Pet Drug Revenue Market Share by Region (2016-2026)

Figure 59. China Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Japan Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South Korea Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. India Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Southeast Asia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Australia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South America Pet Drug Sales Market Share by Type (2016-2026)

Figure 66. South America Pet Drug Sales Market Share by Application (2016-2026)

Figure 67. South America Pet Drug Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East and Africa Pet Drug Sales Market Share by Type (2016-2026)

Figure 71. Middle East and Africa Pet Drug Sales Market Share by Application (2016-2026)

Figure 72. Middle East and Africa Pet Drug Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. UAE Pet Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

Sample Request is not available